Clinical Trials Directory

Trials / Completed

CompletedNCT04456751

Is Redo Pediatric Cardiac Surgery a Risk Factor for Transfusion?

Is a Reintervention for Pediatric Cardiac Surgery Associated With Higher Blood Transfusion Requirements ?

Status
Completed
Phase
Study type
Observational
Enrollment
2,439 (actual)
Sponsor
Brugmann University Hospital · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers

Summary

In pediatric cardiac surgery, transfusion requirements are associated with age, development status, pathology, type of surgical intervention and extracorporeal bypass. In adult cardiac surgery, reinterventions (redo)are clearly linked to higher transfusion rates. The investigators want to study if this association is also true in pediatric cardiac surgery.

Detailed description

Whereas in adult cardiac surgery, redo-interventions are clearly linked to a higher transfusion rate, this is not really known in paediatric cardiac surgery. In this retrospective study, the investigators will analyse our database for paediatric cardiac surgery patients aged 0-16 years and operated between 2002 and 2017. Patients with a single cardiac surgery will be compared to patients with a second cardiac operation under extracorporeal bypass. The investigators will test the variables for normal distribution using a Shapiro-Wilk test. Non normal distributed variables will be compared by a non-parametric test (Mann Whitney U), frequency analysis will be done by a Chi-Square test. A univariate analysis will determine predicting factors for transfusion. Factors with a P value \< 0.1 will be analysed by a multivariate analysis to determine independent factors for transfusion. Odds with 95% confidence intervals will be calculated. A P value \< 0.05 will be considered statistically significant.

Conditions

Interventions

TypeNameDescription
OTHERRedo opPatients with a redo operation

Timeline

Start date
2020-07-02
Primary completion
2020-08-15
Completion
2020-08-15
First posted
2020-07-02
Last updated
2020-08-26

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04456751. Inclusion in this directory is not an endorsement.